Podcasts about line podcast

Taking a stand against racial bias in the workplace was a big Step Out of Line moment for Catharine Montgomery.Knowing when to walk away and start a new chapter is never easy, but Catharine has reinvented herself and launched The Better Together Agency, a Black woman-founded and AI-forward communications agency that creates integrated campaigns for mission-driven work. Catharine never stops learning and is a champion of AI technology, while also being determined to keep a close eye on social media in this rapidly evolving tech space that continues to place stereotypes on marginalized groups. Catharine has found her confidence. If she could go back and talk to her younger self, she would tell her she is worthy of so much more and to be self-assured at a younger age.In this episode of the Step Out of Line Podcast, “The Chasing Challenges Mindset,” we talk about racial bias, AI technology, and why sometimes you have to step out of line, embrace the challenge, and create your own path.Catharine is principled and committed to her mission. And sometimes, adversity makes you a better entrepreneur. It teaches you how to bounce back, pivot, and keep moving forward.

Andrew Blubaugh is a former marine now serving as a Midwest police officer and passionate firearms instructor. Andrew brings over 20 years of military, private security and law enforcement experience. He also loves the outdoors and hiked the Appalachian Trail.   To learn more about Andrew Blubaugh visit APEXShooting.com or follow him @apex_shooting_and_tactics_llc on Instagram.   RELATED PODCASTS: The Killing Time is Over - SEAL Legend Cory Zillig | Higher Line Podcast #275 Building Better Protectors | Higher Line Podcast #253 Trainer of Warriors | Higher Line Podcast #232   ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

Shipping costs are surging, diesel prices are climbing, global conflicts are threatening critical trade routes, cyberattacks are targeting infrastructure, and the bond market is flashing serious warning signs.In this episode of Behind the Line Podcast, we connect the dots between the Strait of Hormuz, Iran, the war in Ukraine, rising freight and fuel costs, threats to power and water infrastructure, and growing pressure in the U.S. Treasury market.Are these isolated problems, or are multiple pressure points beginning to converge?We break down what's happening, why it matters to American families, and practical steps you can take to strengthen your household preparedness, financial resilience, and ability to weather disruptions.Preparedness isn't panic. It's personal responsibility.#BehindTheLinePodcast #PerfectStorm #SupplyChain #DieselPrices #EconomicCrisis #Iran #StraitOfHormuz #UkraineWar #CyberSecurity #CriticalInfrastructure #BondMarket #TreasuryYields #EconomicWarning #Preparedness #EmergencyPreparedness #FoodSecurity #EnergySecurity #SupplyChainCrisis #FinancialPreparedness #NationalSecurity #PersonalResponsibility #ConstitutionalConservative #AmericaFirst #Geopolitics #LeftCoastNews

In the latest episode of The Line Podcast, Matt Gurney and Jen Gerson begin with some news close to home: The Line gets hacked! Well, almost. Luckily, our defences held. Unfortunately, the list of people who might want to hack us is longer than we'd like. We piss a lot of people off.This episode is brought to you by Cameco. Canada is entering a decisive decade for energy, and the nuclear reactor we choose now matters. Incomplete designs carry real risk of delays and cost overruns, and we cannot afford to spend years designing a reactor before construction begins. That is why Cameco believes the AP1000 reactor is the right choice for Canada. It is already operating globally and ready now, with 100 percent Canadian ownership and strong participation from Canadian suppliers.The AP1000 reactor means job creation and supplier contracts, energy security at home, and significant investment staying right here in Canada.A proven design, built on time and on budget. That is how we build Canada.Learn more at ap1000.cameco.com.Then it's on to the main event: Mark Carney goes to New York and talks to American reporters, including about the possibility of a U.S. attack on Canada. Matt is irritated by the reaction back home. The military considering bizarre and unlikely scenarios isn't evidence that the prime minister has lost his mind. It's literally the military's job to think about weird scenarios before they happen. In attacking Carney over this, Matt argues, his critics are really attacking the Canadian military for doing exactly what Canadians pay it to do.This episode is also brought to you by Cardus. For years, Ayaan Hirsi Ali was one of the most famous atheists in the world. Then she converted to Christianity. Now she argues that faith is the key to renewing Western civilization. Hear her make the case live in Calgary, October 8th, at the 2026 Ian Shugart Lecture, hosted by the think tank Cardus. Get your tickets at Cardus.ca/ayaan.Next, Jen provides an update from Alberta, where there is, as usual, a lot going on. She suspects Danielle Smith may be coming a little unhinged. Matt, ever the diplomat, decides to court controversy by asking when so many Albertans turned into Torontonians, terrified of saying anything that might offend somebody. You guys used to be braver than that.Finally, your hosts discuss the horrific attack on a synagogue in Belleville, Ontario, before turning to two media stories they think listeners should know about. And Matt has a question for Jen: is the CBC actively trying to get itself scrapped?This episode is also brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This September we're focusing on the “made-in-Canada” part. One way to leverage existing Canadian government investments in biomanufacturing would be to make it easier for Canadian innovators to develop their discoveries into therapies here in Canada.Aside from organizations like BioCanRx, there are few funding sources for the “translational research” activities necessary to build the significant body of evidence required for clinical trial approval from Health Canada — without which these therapies could never reach patients. If funding mechanisms are created to support translational research in Canada, more Canadian discoveries can generate work for Canada's biomanufacturing facilities — leading to more sovereign capacity, and more therapies made in Canada for Canadian patients.But how could we make sure new investments aren't wasted? More on that next week. Visit BioCanRx.com to learn more.All that and more in the latest episode of The Line Podcast. Check out, but do not hack!, our main page at ReadTheLine.ca. Like and subscribe!

In this episode of On The Line, Jen Gerson checks in with Greenland and Europe. Canadians seem increasingly open to closer ties with non-U.S. Western allies — but what do those allies think about us?This episode is brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This September we're focusing on the "made-in-Canada" part. One way to leverage existing Canadian government investments in biomanufacturing would be to make it easier for Canadian innovators to develop their discoveries into therapies here in Canada. Aside from organizations like BioCanRx, there are few funding sources for the "translational research" activities necessary to build the significant body of evidence required for clinical trial approval from Health Canada — without which these therapies could never reach patients. If funding mechanisms are created to support translational research in Canada, more Canadian discoveries can generate work for Canada's biomanufacturing facilities –– leading to more sovereign capacity, and more therapies made in Canada for Canadian patients. But how could we make sure new investments aren't wasted? More on that next week. Visit BioCanRx.com to learn more.First, Markus Bernsen joins Jen to discuss the reported U.S.-Greenland agreement, what remains unknown, and why the negotiations have caused so much anxiety in Greenland and Denmark. They discuss military access, investment, sovereignty, and the damage already done to the Denmark-U.S. relationship.This episode is also brought to you by the Forest Products Association of Canada. Every budget season brings endless ideas for how Ottawa should spend. But some of the best ways to strengthen Canada's economy don't require a massive price tag.For Canada's forest products sector, real growth starts with dismantling made-in-Canada barriers: cutting regulatory duplication, fixing supply chain bottlenecks, securing predictable, cost-competitive access to fibre, and creating more certainty for investment.We can't control every global challenge facing our industry, but we can remove the barriers created right here at home.Discover how smarter policy drives economic growth at FPAC.ca.Then Brussels-based foreign correspondent Jack Parrock joins Jen to discuss Canada's push for closer ties with the European Union. What would “associate membership” actually mean? How much is substance and how much is symbolism? And could Canada and Europe build deeper links in trade, payments and defence as both reconsider their dependence on the United States?From Greenlandic sovereignty to diplomacy in Strasbourg, it's a look at how the Western alliance is being reshaped — and where Canada might fit.This episode is also brought to you by Cardus. For years, Ayaan Hirsi Ali was one of the most famous atheists in the world. Then she converted to Christianity. Now she argues that faith is the key to renewing Western civilization. Hear her make the case live in Calgary, October 8th, at the 2026 Ian Shugart Lecture, hosted by the think tank Cardus. Get your tickets at Cardus.ca/ayaan.Check out our main page at ReadTheLine.ca, and as always, like and subscribe. Stay tuned Friday for the next episode of The Line Podcast.

Gas and diesel prices are hammering American families, truckers, farmers, commuters, and small businesses. At the same time, President Donald Trump has described higher fuel costs as a “small price to pay” in connection with preventing Iran from obtaining a nuclear weapon.On this episode of Behind the Line Podcast, we examine the growing disconnect between Washington and the working Americans actually paying the bill at the pump.We break down the impact of the Iran conflict on global energy markets, the importance of the Strait of Hormuz, rising gasoline and diesel prices, and the ripple effects that higher transportation costs can have on groceries, freight, farming, small businesses, and household budgets.Preventing a nuclear-armed Iran raises serious national-security concerns. But what happens when the economic cost of foreign policy lands squarely on Americans already struggling with the cost of living?How much economic sacrifice should Americans be expected to make for national security, and how should political leaders address that burden?Behind the Line Podcast takes on the politics, public safety, national security, economic issues, and government decisions affecting everyday Americans.Subscribe and join the conversation.#BehindTheLinePodcast #GasPrices #DieselPrices #Trump #Iran #IranConflict #OilPrices #EnergyPrices #StraitOfHormuz #CostOfLiving #Inflation #WorkingClass #AmericanEconomy #EnergyPolicy #NationalSecurity

In the latest episode of The Line Mega Productivity Podcast, recorded on September 18th, 2026, prospective associate EU members Matt Gurney and Jen Gerson begin with Prime Minister Mark Carney's trip to the continent. The reception was remarkably warm, as Canada and Europe explore a much closer strategic relationship. This episode is brought to you by Cameco. Canada is entering a decisive decade for energy, and the nuclear reactor we choose now matters. Incomplete designs carry real risk of delays and cost overruns, and we cannot afford to spend years designing a reactor before construction begins. That is why Cameco believes the AP1000 reactor is the right choice for Canada. It is already operating globally and ready now, with 100 percent Canadian ownership and strong participation from Canadian suppliers.The AP1000 reactor means job creation and supplier contracts, energy security at home, and significant investment staying right here in Canada.A proven design, built on time and on budget. That is how we build Canada.Learn more at ap1000.cameco.com.Your hosts discuss the trip, the PMO's continuing inability to develop a workable communications strategy and the credibility problems that creates. But the most fascinating part may be the American reaction. Donald Trump has now threatened retaliation over Canada's growing ties with Europe. Matt and Jen wonder: is Washington finally beginning to realize just how badly it may have miscalculated?This episode is also brought to you by Cardus. For years, Ayaan Hirsi Ali was one of the most famous atheists in the world. Then she converted to Christianity. Now she argues that faith is the key to renewing Western civilization. Hear her make the case live in Calgary, October 8th, at the 2026 Ian Shugart Lecture, hosted by the think tank Cardus. Get your tickets at Cardus.ca/ayaan. Next, they turn to the Canada Investment Summit hosted by the prime minister in Toronto. There's a lot to like about the ambition behind it, your hosts agree — but Canada now has to actually deliver the projects it is promising. And then there's Stephen Harper. The former Conservative prime minister closed the summit by praising the initiative and arguing that Canada must reduce its reliance on the United States. Jen connects Harper's remarks to a point Matt made in his column this week and goes considerably further: did Harper just politely drive a stake through the heart of Pierre Poilievre's political career? Jen thinks so, and says so on the record: it's over, Tories. Poilievre is never going to win. Move on.Finally, Matt provides a quick update on some increasingly serious warnings from Canada's European allies about the possibility of Russian attacks against NATO territory. Jen then brings things home with a major update from Alberta, now just one month away from its October 19 referendum.This episode is brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This September we're focusing on the “made-in-Canada” part.Federal and provincial governments have made strong investments in the biomanufacturing sector, but Canada's drug development ecosystem has contracted over time, and there is not yet enough domestic demand to fully utilize many of these advanced biomanufacturing facilities. This becomes a sovereignty problem. If our biomanufacturing facilities can't remain in operation, we lose the ability to develop and manufacture homegrown therapies. We wait for therapies developed in other countries to make their way here –– with no control over when that might happen. BioCanRx requires the research projects it funds to work with Canadian facilities whenever possible, which has helped build and sustain networks across Canada –– but there is still a lot of untapped potential.How can we make sure our infrastructure isn't sitting idle? More on that next week. Visit BioCanRx.com to learn more.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca. Like and subscribe!#TheLinePodcast #MarkCarney #PierrePoilievre #StephenHarper #CanadianPolitics #CanadaUSRelations #Europe #Russia #AlbertaPolitics #CurrentAffairs

“You're creating change just by being you.” — Stephanie Kaplan Losing her father at 14 was a defining moment for Stephanie Kaplan. The monarch butterfly became her beacon of light on her wedding day in 2020, and she was escorted down the aisle with a kaleidoscope of monarch butterflies serendipitously. It was a sign to Stephanie that her father was indeed with her. After working in tech and sales, Stephanie took the leap into entrepreneurship and became a coach, helping founders, executives, and investors navigate the personal side of leadership, growth, and success.In this episode of the Step Out of Line Podcast, “Learning How To Define Happiness,” we talk about recognizing your potential, trusting your path, and knowing that no one can take away your gifts or what you're capable of creating.Because happiness might just begin with seeing yourself and your possibilities more clearly.

In the latest episode of The Line Podcast, recorded on September 11th, 2026, Matt Gurney and Jen Gerson begin by marking the 25th anniversary of the 9/11 terrorist attacks. They reflect on how profoundly America changed after that morning, how the world changed with it, and how the media environment has transformed in the quarter-century since. They also consider how an attack on that scale would be covered today. Their conclusion? Worse. Much worse.This episode is brought to you by Cameco. Canada is entering a decisive decade for energy, and the nuclear reactor we choose now matters. Incomplete designs carry real risk of delays and cost overruns, and we cannot afford to spend years designing a reactor before construction begins. That is why Cameco believes the AP1000 reactor is the right choice for Canada. It is already operating globally and ready now, with 100 percent Canadian ownership and strong participation from Canadian suppliers. The AP1000 reactor means job creation and supplier contracts, energy security at home, and significant investment staying right here in Canada. A proven design, built on time and on budget. That is how we build Canada. Learn more at ap1000.cameco.com.Next, your hosts turn to drones. Canada is partnering with Ukraine as warfare rapidly evolves, and Matt explains why the deal makes a great deal of sense for both countries. Ukraine has extraordinary real-world expertise in drone warfare, while Canada urgently needs to build up its own capabilities. But buying and building drones is the easy part. What exactly is Canada going to do with them? Where will they be stored? How quickly could they be deployed? And under what circumstances might Canada actually use them in, ahem, contingencies? The technology is moving quickly. Canadian defence policy will have to keep up.This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Finally, Matt and Jen wrap up with a grab bag of looming problems. The Canada–U.S. trade war has become strangely lower-energy on the American side, and they discuss some of the reasons Washington may be increasingly hobbled in pursuing it. Then there's time for a quick tour through the AI apocalypse and the latest on Alberta's referendum.This episode is also brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This September we're focusing on the “made-in-Canada” part. Since 2015 BioCanRx has supported the Canadian-Led Immunotherapies Collaborative, or CLIC, in building a truly Canadian pipeline so Canadian patients don't have to wait for cancer therapies developed elsewhere to reach a clinical trial here.In the first iteration, genetic engineering happened in labs in Vancouver, a lab in Ottawa created a viral delivery system, and a facility in Victoria modified each patient's immune cells. The resulting therapy was shipped to a research-intensive hospital where the patient received it. More than 100 patients in B.C., Alberta, Manitoba, and Ontario received treatment. Now the network is growing: new biomanufacturing facilities are preparing to produce cells in Calgary and Ottawa, and new clinical trial sites are being onboarded in other provinces. CLIC technology is being used in three active Canadian clinical trials, with more on the way.So when it comes to producing made-in-Canada cancer immunotherapies, Canada isn't starting from scratch. Thanks to BioCanRx for continuing to help us share these stories. Visit BioCanRx.com to learn more.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca. Like and subscribe.#TheLinePodcast #September11 #CanadaUSRelations #CanadianPolitics #Ukraine #DroneWarfare #CanadianForces #TradeWar #ArtificialIntelligence #AlbertaPolitics

In the latest episode of The Line Podcast, Jen Gerson speaks with Bloomberg senior White House correspondent Josh Wingrove about the collapse of the Canada–U.S. trade deal, the politics behind it, and why Canadians and Americans increasingly seem to be talking past each other.This episode is brought to you by Cameco. Canada is entering a decisive decade for energy, and the nuclear reactor we choose now matters. Incomplete designs carry real risk of delays and cost overruns, and we cannot afford to spend years designing a reactor before construction begins. That is why Cameco believes the AP1000 reactor is the right choice for Canada. It is already operating globally and ready now, with 100 percent Canadian ownership and strong participation from Canadian suppliers.The AP1000 reactor means job creation and supplier contracts, energy security at home, and significant investment staying right here in Canada.A proven design, built on time and on budget. That is how we build Canada.Learn more at ap1000.cameco.com.Jen and Josh unpack the breakdown of the latest negotiations, including the competing Canadian and American accounts of what happened and the domestic political pressures shaping both governments. They discuss what Washington actually wants from Canada, how the dispute looks from inside the United States, and what Canadians may be misunderstanding about the political forces driving American policy.This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage. Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how. Find them Fractional-Execs.ca.They then widen the lens to the broader state of U.S. politics: Donald Trump's hold over the Republican Party, the strength of America's democratic guardrails, the coming midterms, and where the country may be heading politically. Finally, they consider what all of this means for Canada—and for a bilateral relationship that Canadians can no longer take for granted.This episode is also brought to you by BioCanRx. Over the summer we partnered with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This September, we want to better understand the “made-in-Canada” part. Many drugs discovered in Canada leave to be developed and commercialized in the United States –– with the benefits accruing there. Completely made-in-Canada immunotherapies are rare because Canada doesn't have a major domestic pharma company to support the development costs or regulatory requirements. BioCanRx is one of the rare not-for-profits with the capacity and expertise to help move Canadian-discovered and manufactured immunotherapies towards the market, both through translational research funding and regulatory support. Promising examples include several therapies now in clinical trials through the Canadian-Led Immunotherapies Collaborative, or CLIC, which are fully designed and manufactured in Canada to target certain blood cancers and, more recently, solid tumours. More on those next time. Visit BioCanRx.com to learn more.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca. Like and subscribe!#TheLinePodcast #CanadaUSRelations #TradeWar #DonaldTrump #MarkCarney #CanadianPolitics #USPolitics #JoshWingrove #USMidterms #CurrentAffairs

"Life is preparing you for something bigger."That's what Taylor Clarke's mom told her at age 7, in the middle of recovering from her first of three brain surgeries that she would endure throughout her childhood and into her early 20s. Years later, the roles reversed: when her mom got cancer, Taylor became her caretaker. That kind of reciprocity, showing up for each other when it matters most, is what has shaped everything about who Taylor is today.Now Taylor is the founder of Amborella Organics, alongside her husband, a botanical candy brand built on that same resilience. Its eco-friendly lollipops carry the message: eat one, then plant the stick to grow your own herbs and flowers.Taylor didn't study business but majored in literature. As she put it, that course of study was basic entrepreneurship training: find a point of view, then build the case to prove it. Sound familiar? And she hasn't compromised her business values, as sustainability runs through every stage of production, no exceptions.In this episode of the Step Out of Line Podcast, “All You Need Is a Lollipop and a Dream,” we talk about adversity turned into purpose, from growing up in and out of hospitals to caregiving, life as a mom, having a husband who is both a dreamer and business partner, and more.

Send us Fan MailIf you are tired of listening to my voice... Carlos and Mike from Off the Racing Line Podcast join me to talk about their goals, mission, and what their podcast is all about. If you need an alternative or you need more racing podcasts in your life... check them out! Support the show

In the latest episode of The Line Podcast, recorded on August 28th, 2026, Matt Gurney and Jen Gerson begin with the rapidly escalating Canada-U.S. trade war, which somehow managed to get very stupid, very quickly. Ontario Premier Doug Ford told Donald Trump to kiss his ass; Trump responded by signing an executive order renaming Lake Ontario “Lake America.” Your hosts discuss just how weird this confrontation could get—and whether what we're watching now is merely the opening phase of something much longer and more serious.This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.comNext, Matt and Jen argue that Canada still needs to get much better at fighting the communications and information war. The United States has recently confronted Chinese influence operations aimed at shaping its domestic politics, which raises an uncomfortable question: how confident should Canadians be that nobody is trying the same thing here? And if information operations are becoming a normal instrument of state power, should Canada be thinking seriously about developing the capacity to play offence as well as defence?This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementers, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Finally, your hosts turn to a CBC controversy that sounds considerably crazier in the headlines than it actually is. CBC's longstanding journalistic policy is to avoid independently designating particular acts as “terrorism,” preferring to use the term with attribution—a policy shared in various forms by several major international news organizations. But an internal reminder applying that rule to the 9/11 attacks has predictably exploded into a controversy suggesting that Canada's public broadcaster somehow doesn't believe 9/11 was terrorism. Matt and Jen explain why the underlying policy isn't nearly as stupid as it looks—and also why, in this particular case, it's still dumb enough that CBC should fix it.This episode is also brought to you by BioCanRx. Through our partnership with federally-funded Canadian not-for-profit BioCanRx this summer, we're talking about potential solutions for the problems that are limiting Canada's ability to domestically develop new drugs, especially immunotherapies for cancer. Today: new methods for biomanufacturing.Immunotherapies are created using living components –– sometimes even our own cells — so they're extremely complex and costly to create and deliver to patients. That's why in the United States, only one in five people who could be treated by a personalized therapy like CAR T can afford to receive it. Fortunately, new manufacturing paradigms have the potential to increase accessibility. Similar to how 3D printers can efficiently produce individual mechanical components, closed-system manufacturing creates immunotherapy drugs in self-contained, benchtop machines that enhance efficiency through automation. This turns many hospitals across Canada into potential manufacturing sites and makes scaling up the delivery of personalized therapies to individual Canadian patients a real possibility.Some new manufacturing technologies can even scale from producing a single patient's personalized dose to mass-producing doses for 100,000 patients per day — meaning they could mass-produce vaccines during an emergency.BioCanRx is working with federal partners to understand where this technology can fit within our biomanufacturing regulatory structure, and how AI might help. More on that next time. Learn more at BioCanRx.com.All that and more in the latest episode of The Line Podcast.#TheLinePodcast#CanadaUSRelations#DonaldTrump#DougFord#MarkCarney#TradeWar#ForeignInterference#CBC#CanadianPolitics#CurrentAffairs

What does the future look like when construction, technology, and the people who do the work come together?From the top of the NASDAQ Tower in Times Square, Joshua D. Mellott sits down with KP Reddy, Founder and CEO of Zero RFI, for a conversation that goes far beyond technology.They talk about AI and where technology is taking the construction industry, but the conversation quickly moves into something bigger: leadership, parenting, mentorship, hardship, and our responsibility to prepare the next generation.Technology will continue to change the way we work, but people still matter. Experience matters. And the knowledge we gain means very little if we aren't willing to pass it on.Whether it's our children, the people on our teams, or the person working beside us, we have a responsibility to teach, mentor, and share what we've learned so the next generation can take our industry, our culture, and our society further.KP understands construction. He understands technology. And he believes in finding better solutions while never losing sight of the people who actually do the work.Step Up to the Line and join the conversation.THE LINE Podcast x BLACKLINELifting the view of the skilled trades.#TheLine #Blackline #KPReddy #ZeroRFI #Construction #SkilledTrades #AI #Technology #Leadership #Mentorship --------------------------WHERE TO WATCH:Spotify ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://open.spotify.com/show/07rT0hF...Apple ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://podcasts.apple.com/us/podcast...-------------------------FOLLOW JOSH:X: https://x.com/Joshuadmellott⁠⁠⁠⁠⁠⁠⁠⁠⁠... / joshuadmellott LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok:⁠⁠⁠⁠⁠⁠⁠⁠ / ucc11qg6hxwp7tmvmr_sv7vg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ --------------------------FOLLOW BLACKLINE: @blacklineltdInstagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / blacklinelt. .Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/profile.php?...LinkedIn: / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / @blacklineltd Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.blacklineltd.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠--------------------------EXPLORE THE PODCAST⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify: https://open.spotify.com/show/07rT0hF...Apple: https://podcasts.apple.com/us/podcast...

In the latest episode of The Line Podcast, recorded on August 21st, 2026, Matt Gurney joins remotely from Chicago as he makes his way home to Canada after a family event. Sorry, elbows uppers.This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.comThe first segment is, admittedly, a bit of a placeholder. Until there is an actual Canada-U.S. trade deal to read, it's difficult to have firm opinions about it — assuming there even is a deal. Your hosts walk through what's been reported so far and explain why they're reserving judgment until the details are public. That said, Matt highlights one rumoured provision that, if true, would represent a uniquely Canadian style of spectacularly self-inflicted policy failure. For the deeper analysis, look for Sunday's Dispatch.This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementers, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Next, Matt and Jen examine the early political reaction to both the negotiations themselves and the rumours surrounding the deal. Both were struck by comments this week from Manitoba Premier Wab Kinew. With a combination of clarity and folksy charm, Kinew articulated what your hosts believe is the strongest criticism of Mark Carney's handling of the America file they've heard so far. They're not suggesting Kinew is about to jump into federal politics. He doesn't need to. If someone can make a compelling case that this deal is bad for Canada, Carney could find himself under pressure from both the left and the right.This episode is also brought to you by BioCanRx. Through our partnership with federally-funded Canadian not-for-profit BioCanRx this summer, we're talking about potential solutions for the problems that limit Canada's ability to domestically develop new drugs, especially immunotherapies for cancer.Today: Canada's biomanufacturing capacity. A biomanufacturing industry, like any other industry, does not appear at the swipe of a bureaucrat's pen. Simply allocating money to a new economic development program doesn't replace the years of effort necessary to help a sector put down lasting roots. Canada already has many building blocks in place. For example, infrastructure developed for pandemic readiness after COVID, and money invested in research facilities across Canada, can be leveraged to give us a head start — but they need to be coordinated and given steady work.BioCanRx supports core Canadian biomanufacturing facilities and connects them with active Canadian research projects, making sure both sides have resources and the chance to gain experience. But more activity is needed to ensure these facilities can build up expertise, maintain readiness, and foster innovation. Building this capacity can position Canada to develop new drugs more quickly — and to be ready for a health emergency, all while delivering products to Canadian patients today.There are promising paradigm shifts on the horizon that could change the way we manufacture biologic products like immunotherapies. More on that next week. Visit BioCanRx.com to learn more.Finally, Matt reflects on his recent travels through the United States. There are many ways Canada will never compete directly with America — they're simply bigger and richer. But there are also areas where Canada once had a visible edge and has quietly lost it. Chicago has always had more crime and a higher murder rate than Toronto. That's nothing new. What is new, Matt argues, is that downtown Chicago is now noticeably cleaner and better maintained than downtown Toronto. That's not a consequence of American military power, economic dominance, or Donald Trump. That's a Canadian policy failure. And the really damning part? Downtown Detroit is cleaner than Toronto now, too.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca. Like and subscribe! #TheLinePodcast#MarkCarney#CanadaUSRelations#TradeDeal#CanadianPolitics#WabKinew#Toronto#Chicago#PoliticalAnalysis#CurrentAffairs

It took more than 30 years for Lynn Power to find her way back to her creative self, and the journey was anything but linear.After leaving her role as CEO of a leading advertising company, Lynn stepped away from the ad world and reinvented herself as an entrepreneur, founding MASAMI, a clean, premium haircare brand, as well as Isle de Nature, a home fragrance company, and the Power Beauty Collab, a clean, sustainably minded indie beauty and wellness business community.Then came a cancer scare that changed everything. It forced Lynn to take a hard look at her priorities and redefine what truly mattered. Her takeaway? Chase joy. Make room for creativity. Have more fun before it's too late.For Lynn, stepping outside the lines is second nature. She stays busy, stays curious, stays creative, and most importantly, is committed to living life to the fullest.In this episode of the Step Out of Line Podcast, “The Reinvention of Lynn Power", we talk about reinvention, creativity, entrepreneurship, and what it means to finally give yourself permission to follow your own path...which might just make you move to Italy.

In the latest episode of The Line Podcast, recorded on August 14th, 2026, Matt Gurney and Jen Gerson begin with a lengthy discussion of the state of the Canada–U.S. trade war. This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.comYour hosts are in complete agreement: Canada should not accept a bad deal. A bad deal wouldn't buy lasting peace, they argue — it would simply set the stage for the next round of American demands. In their view, there is no stable middle ground. Canada either resists now or surrenders now. They also examine the unusual political psychology of the Americans currently running the White House, while cautioning listeners not to expect salvation from the Democrats. A future Democratic administration may be less abrasive, but it won't undo the underlying shift in American policy. As Matt puts it, quoting the late Chris Cornell, "Arm yourselves because no one else here will save you." That includes the likes of Gavin Newsom and Chuck Schumer.This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementers, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.From there, the hosts turn to Alberta and a fascinating Toronto Star investigation tracking the flow of money supporting the separatist movement. The reporting closely matches what both Line editors had already concluded independently. Jen offers an update from the ground in Alberta, while Matt steps back to consider the national implications. Both arrive at the same frustrating conclusion: it would be helpful if Canada's institutions were capable of recognizing foreign interference when it was happening. Recent history suggests we're not only bad at it — we don't even seem particularly interested in trying.Finally, Matt and Jen close with a friendly disagreement over the controversy surrounding Prime Minister Mark Carney's vacation in Italy. They don't see eye to eye, and by the end of the conversation it's clear Matt is unlikely to invite Jen along on his next European vacation. If you'd like to help fund that hypothetical trip, your hosts suggest the usual: like, subscribe, and donate generously.This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit. This summer, BioCanRx and The Line have been talking about potential solutions for the problems that are limiting Canada's ability to domestically develop new drugs, especially immunotherapies for cancer.We ask a lot of Canadian cancer researchers. The work required to discover new therapies for numerous diseases, and get them to patients, costs far more than the half-billion dollars invested in cancer research by all levels of government and charities — and often the available grants specialize in only one part of the spectrum: discovery. We need to be sure we're supporting researchers at every step of this complex scientific and regulatory process.BioCanRx has proved you can meaningfully support this part. The entire team is only 12 people, but they know what it takes to do things like submit a clinical trial application or safely manufacture a drug, so the researchers they fund are held to firm, realistic standards that make sense in the real world of Canadian health-care systems and industry. That's how a tiny not-for-profit has helped bring 16 new drugs to clinical trials that have treated more than 400 people in just 10 years.But research is only one part of the puzzle — can we manufacture new therapies in Canada? More on that next time.Visit BioCanRx.com to learn more.All that and more in the latest episode of The Line Podcast.#TheLinePodcast#MarkCarney#CanadaUSRelations#TradeWar#CanadianPolitics#AlbertaPolitics#ForeignInterference#GavinNewsom#ChuckSchumer#CurrentAffairs

In the latest episode of The Line Podcast, recorded on August 7th, 2026, Matt Gurney is joined by guest host Scott Stinson, filling in for Jen Gerson. They begin with the latest twists in Canada-U.S. relations, asking just how much Prime Minister Mark Carney can concede to the Americans before the political costs become too high at home. Both hosts suspect the answer is probably more than many Canadians would expect. They also discuss how fortunate Carney is to be making these decisions while facing relatively weak opposition, with Pierre Poilievre enduring another difficult week. Matt explains why the Conservative leader continues to struggle to gain traction.This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To larn more, visit ap1000.cameco.com.The conversation then shifts to Ontario politics, where many of the same themes are playing out. It should be a quiet summer at Queen's Park, but instead the Ford government finds itself taking hits from all directions, including from an opposition party that doesn't currently have a permanent leader. Matt and Scott discuss why the Ontario NDP appears so adrift. New Democratic governments are commonplace elsewhere in Canada, so why does the party remain unable to break through in Ontario, even with Doug Ford leading the PCs and the Liberals still searching for direction? Matt has a theory.This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Finally, Scott brings listeners up to speed on the growing controversy surrounding Gianni Infantino and FIFA. The discussion broadens into a look at why major sports organizations seem almost inevitably to attract corruption—and why it's so fascinating to watch the rare moments when those organizations actually decide to push back.This episode is also brought to you by BioCanRx, a Canadian not-for-profit working to help Canadian researchers and companies develop new drugs, especially immunotherapies for cancer.A key challenge for Canada will be familiar to anyone trying to grow a business here: we have some of the brightest people in the world, we just can't keep enough of them. Canada is home to researchers making breakthrough discoveries every day. But bringing a new therapy from the lab to patients takes more than great science. It also requires specialists who know how to manufacture complex products, navigate regulatory approval, and help new treatments be integrated into the health-care system. Too often, that expertise leaves Canada before the work is done.BioCanRx has supported hands-on training for more than 900 trainees over the past decade, but without a strong domestic industry, retention becomes a challenge. So how do we keep these highly-skilled people? Next time we'll talk about how changing what we incentivize can maximize the impact of research money Canada already spends to sustain more drug development here in Canada. For now, go to BioCanRx.com to learn more.All that and more in the latest episode of The Line Podcast.CHAPTERS00:00 Intro01:37 Can Carney keep conceding? (Yup!)26:39 Fall of Ford48:34 FIFA WTF#TheLinePodcast#MarkCarney#CanadianPolitics#CanadaUSRelations#PierrePoilievre#DougFord#OntarioPolitics#FIFA#GianniInfantino#CurrentAffairs

Like a phoenix rising from the ashes, Mary-Ann Massad has rebuilt her life time and again to become the woman she is today: CEO of Knowsys Group Ltd., author, and a compassionate, empathetic leader.Mary-Ann learned the true meaning of care and compassion at a young age while looking after her brother. Throughout her life, she has endured profound loss, fear, heartbreak, and countless battles that tested her resilience. Yet she has never separated her heart from her role as a CEO, leading with both strength and empathy.Forced to put away her dolls and childhood far too soon, Mary-Ann's early experiences became the foundation of her entrepreneurial journey. From caring for her brother and aging parents to supporting a husband with mental illness, facing her son's cancer diagnosis, and recovering from a devastating bike accident, she has endured more than most can imagine.In this episode of the Step Out of Line Podcast, "The Phoenix Shall Rise Again," Mary-Ann shares her remarkable journey. We talk about her childhood, what it was like to be a caregiver before finding herself on the receiving end of care, the lessons she's learned through unimaginable adversity, and why she continues to choose hope, resilience, and life.Mary-Ann's story is a powerful reminder that resilience isn't about avoiding hardship; it's about rising every time life knocks you down.

Jeremy Baumann, CEO of Corporate Security Advisors, went from small town cop in rural America to coordinating international corporate security serving the pharmaceutical sector. Baumann shares challenging situations early in his career as a beat cop and the importance of going hands on. He also discusses the professional transition from LEO to corporate security. Listen and learn from world class security expert.   To learn more about Jeremy Baumann and Corporate Security Advisors visit CorporateSecurityAdvisors.com   RELATED PODCASTS: Fear or Lust | Higher Line Podcast #73 No Escape: Bail Enforcement Specialist | Higher Line Podcast #97 Child Predators // Higher Line Podcast #195   ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.  

In the latest episode of The Line Podcast, recorded on July 31st, 2026, Matt Gurney and Jen Gerson begin by asking whether Canada's governments are actually prepared to make the sacrifices required to defend the country's interests. Both come away disappointed. Matt points to the federal government's decision to block the expansion of an airport in the Toronto area because it was locally controversial and could complicate an upcoming Liberal byelection. If a government isn't willing to risk losing even a single seat to get important things done, Matt argues, then it's never going to get important things done.This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.Next, Jen checks in from Alberta with an update on the separatist movement. While recent polling shows federalist forces comfortably ahead, she's far from reassured. The problem isn't the raw level of support for separation, which remains relatively low. It's the intensity. Separatists are deeply motivated, while federalists may assume victory is inevitable and fail to organize or even show up. If that happens, Jen warns, the result could be much closer than today's polls suggest.This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network dedicated to cutting edge cancer immunotherapy research that they're helping Canadian researchers bring from labs to patients in clinical trials — all in Canada.If a drug is discovered in a Canadian lab, and conducts successful clinical trials in Canada, there's a chance it will be launched in Canada. So how do we get more drugs out of Canadian labs and keep them here? Every year around $500 million is spent on Canadian cancer research, but 70 per cent of that is for early-stage work — discovering whether a therapy can do something in the lab. That leaves limited resources for the complex and often disjointed process of moving Canadian innovations from discovery to a clinical trial and hopefully into the health system.BioCanRx has stepped into the gap. They specialize in “translational research” — the unsexy work that makes for boring press releases, but gets results: 16 Canadian cancer immunotherapy clinical trials in just a decade, treating more than 400 patients.Thanks to this, BioCanRx has first-hand experience with the systemic disconnects that are trapping discoveries in Canadian labs, or sending them out of the country to be developed. They have straightforward ideas about how to fix the problems, and spoiler alert: the answer isn't just “add more money.” Stay tuned to learn more in coming weeks, and visit BioCanRx.com to learn more.Finally, Matt raises reports about Jagmeet Singh's possible next job after politics, and he's unimpressed. Jen offers a different perspective, suggesting that perhaps there's something to be said for a political class that takes care of its own after public service. Your hosts don't reach a firm conclusion — but they lay out both sides and leave it to listeners to decide.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca.#TheLinePodcast#CanadianPolitics#MarkCarney#AlbertaPolitics#Federalism#JagmeetSingh#LiberalParty#PoliticalAnalysis#CanadaPolitics#CurrentAffairs

Retired Navy SEAL Cory Zillig returns to talk about his new book and reinvigorating The Site, a large Midwest firearms training center. Cory served twenty years as a SEAL and thirteen of those specifically on SEAL Team SIX.   To learn more about Cory Zillig's book visit CoryZillig.com or follow him @CoryZillig on Instagram. BOOK: https://coryzillig.com THE SITE: https://thesitetraining.com FIRST ZILLIG PODCAST: https://higherline.libsyn.com/dad-the-killing-season-is-over-higher-line-podcast-102   RELATED PODCASTS: Manners from a SEAL | Higher Line Podcast #98 SEAL Author | Higher Line Podcast #77 SEAL TURNED Director of Training | Higher Line Podcast #85   --- Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

In the latest episode of The Line Podcast, recorded on July 24th, 2026, hosts Matt Gurney and Jen Gerson set out with the ambitious goal of keeping each segment to a specific, fixed time. They do not succeed.This episode is brought to you by BioCanRx, Ia federally-funded Canadian not-for-profit research network dedicated to cutting edge cancer immunotherapy research that they're helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.If a drug is discovered in a Canadian lab, and conducts successful clinical trials in Canada, there's a chance it will be launched in Canada. So how do we get more drugs out of Canadian labs and keep them here? Every year around $500 million is spent on Canadian cancer research, but 70 per cent of that is for early-stage work –– discovering whether a therapy can do something in the lab. That leaves limited resources for the complex and often disjointed process of moving Canadian innovations from discovery to a clinical trial and hopefully into the health system.BioCanRx has stepped into the gap. They specialize in "translational research" –– the unsexy work that makes for boring press releases, but gets results: 16 Canadian cancer immunotherapy clinical trials in just a decade, treating more than 400 patients.Thanks to this, BioCanRx has first-hand experience with the systemic disconnects that are trapping discoveries in Canadian labs, or sending them out of the country to be developed. They have straightforward ideas about how to fix the problems, and spoiler alert: the answer isn't just 'add more money." Stay tuned to learn more in coming weeks, and visit BioCanRx.com to learn more.They begin by unpacking a remarkable week in Canada–U.S. relations. New details about the Gordie Howe Bridge agreement have emerged, and neither host likes what they see. Combined with another round of American tariffs, Jen argues that Prime Minister Mark Carney has committed his first major political fumble. Matt agrees that it's a setback, but also argues that the White House is undermining its own objectives. In an unusual role reversal, Matt even attempts to make the best possible case for Carney's strategy — despite having been the more hawkish voice in recent months. Jen isn't convinced.This episode is also brought to you by the Forest Products Association of Canada. Canada's forest products sector is not asking Ottawa to start over. The federal government has heard the advice. It has recognized the challenges. And it has put a plan on the table. Now the test is action.That means clearing made-in-Canada barriers: regulatory duplication, transportation bottlenecks, and uncertainty around predictable access to manage our forests. It means working with provinces to protect communities from wildfire risk and giving companies the confidence to invest here at home. Nearly 200,000 Canadians working in this sector are looking for results.The playbook is written. Now Ottawa needs to deliver. Learn more at fpac.ca.The conversation then turns inward to Canadian politics. Jen argues that Carney is trying to do too many jobs himself. That observation leads both hosts to an amusing realization: Carney relies on his communications staff so infrequently that neither of them even knew who the key players were. Matt also argues that while the Conservatives remain effective at opposing the government on domestic issues, they're badly missing the mark on foreign affairs, and that's probably because they don't want to admit some things that they'd find awkward and unpleasant. Jen concludes that Canada really needs the Liberals' strategic instincts combined with the Conservatives' tactical effectiveness. Matt predicts, with characteristic optimism, that the country will somehow end up with neither.This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.Finally, Matt ties together many of the themes from the episode by examining the recent arrest of a man alleged to have been involved in terrorism on behalf of Hamas against Canadian Jews. Matt simply walks through the timeline of the investigation and the eventual arrest. The chronology, he argues, speaks for itself. All that and more in the latest episode of The Line Podcast.#TheLinePodcast#MarkCarney#CanadianPolitics#CanadaUSRelations#TradeWar#GordieHoweBridge#PierrePoilievre#NationalSecurity#PoliticalAnalysis#CurrentAffairs

In the latest episode of The Line Podcast, recorded on July 17th, 2026, Matt Gurney and Jen Gerson keep things refreshingly brief as both are juggling family matters. They begin with Jen's unsuccessful attempt to achieve cottage zen, as she unloads on the latest complaints from American politicians about wildfire smoke drifting south from Canada. Both hosts independently arrive at the same tongue-in-cheek solution: if the Americans don't stop griping, Canada should simply schedule its forest fires for days when the wind is blowing south. (They're kidding. Mostly.) They also discuss Donald Trump's latest bizarre speech and the increasingly revealing comments from senior U.S. officials, who seem unable to hide just how much Prime Minister Mark Carney has gotten under their skin.This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage. Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how. Find them Fractional-Execs.ca.Your hosts then turn to the slow-burning civil war within Canadian conservatism. Jen, still falling well short of cottage zen, has a few things to say. Matt observes that while Carney may be a practicing Catholic, he also seems to have accumulated an extraordinary amount of good karma in previous lives — politically speaking, he's facing remarkably little effective opposition from either the left or the right. Matt also warns the Conservatives that, whether they realize it or not, they're in danger of getting "Jagmeet Singhed." And it's not subtle.This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network focused on cutting-edge cancer immunotherapy research that they're helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.A new treatment for your cancer has been approved. Can you get it? Maybe, maybe not. Canada isn't just one health jurisdiction. At the federal level, Health Canada assesses the safety and efficacy of all drugs and therapies in the country, and in a year — sometimes less — they can approve one for sale in Canada. Once approved, — or sometimes while the assessment is happening— the drug's cost effectiveness is evaluated by Canada's Drug Agency.Then the ball goes to the provinces. They work together to negotiate prices with the drug maker, to confirm that it doesn't duplicate something they're already stocking, and that its potential value justifies its cost. Only after that can it be provided by each province's ministry of health. This process can take years. It's one reason that Canadian innovations leave the country to be developed elsewhere, and why drug companies don't always choose Canada to initially to launch their products. In the U.S., they get FDA approval, set a price, and wait for the market to decide if the price is right. In Canada, Heath Canada approves and lengthy negotiations start, with no revenue or guarantee of future approval.Organizations like BioCanRx are willing to wait out the dry years because they're not-for-profit, but companies with shareholders might skip the Canadian market until they're making big money elsewhere. This means Canadians have to wait on the system for drugs that could save them, and are saving people in other countries. We'll talk more about these problems in the weeks to come. Stay tuned for more.The hosts wrap up by discussing Naheed Nenshi's apology for speaking with an Israeli, which Matt suggests has elevated the Alberta NDP leader to full windbag status. Matt reminds Jen that he used to complain Nenshi needed to get himself into the public eye more often. After this week, he'd like to politely withdraw that recommendation. Jen wonders if maybe this is why he's been invisible — he might just actually be awful at this. Anyway, congrats to Danielle Smith. At this rate, she'll be premier for life.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca, and keep your kindling and torches ready. Wait for the code word.#TheLinePodcast#MarkCarney#CanadianPolitics#DonaldTrump#CanadaUSRelations#ConservativeParty#NaheedNenshi#AlbertaPolitics#PoliticalAnalysis#CurrentAffairs

Ryan Mcguiness is a mechanical engineer crafting new suspension technology for the  racing industry. He worked many years doing research and development for racing shocks. Like any good gearhead, Ryan loves racy parts… especially anything suspension related. To learn more about Ryan's work visit follow PDV Racing Shocks on various social media platforms like facebook and Instagram.   RELATED PODCASTS: Gun Safes – Myths, Lies and Secrets | Higher Line Podcast #266 They Upset a World Wide Industry | Higher Line Podcast #201 Inside Radian Weapons | Higher Line Podcast #81 ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

In the latest episode of The Line Podcast, recorded on July 10, 2026, Matt Gurney and Jen Gerson begin with a discussion of a recent Wall Street Journal piece highlighting Prime Minister Mark Carney's role in pulling Europe back toward a more realistic strategic footing and away from its longstanding dependence on the United States. Canada, and Carney in particular, appear to be taking an unexpectedly prominent leadership role. Your hosts wonder what Washington's response will be, and whether the White House will decide that Canada needs to be reminded who's boss.This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Next, they turn to the proposed Canadian Shield pipeline. On strictly commercial grounds, the project may not make much sense. But Matt and Jen argue that economics may no longer be the primary point. The proposal sends a signal that Canada is prepared to build the infrastructure needed to stand more independently if circumstances require it. That message has value all on its own. As Matt puts it, borrowing from the movie Contact: “Why build one when you can build two at twice the price?”This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network bringing cutting edge cancer immunotherapy research from Canadian labs to patients in clinical trials –– all in Canada.A drug that can treat your cancer is being tested in a Canadian clinical trial, but can you access it? Depends — where do you live? Clinical trials taking place in Canada usually open sites in major centers with research hospitals. Smaller hospitals face many challenges including having enough know-how to deliver experimental therapies, and administrative, legal, and regulatory responsibilities that come with a trial. There are also data and interoperability issues at hospitals that don't routinely participate in research.So if you don't live in a major centre, participating in the trial requires you to relocate there for the duration of treatment –– the cost of the treatment is covered, but the cost of being in the city where it happens is your responsibility. Patient advocacy groups might be able to help with some of those expenses, but this obviously can be a barrier for a lot of Canadians.A therapy might only become available to everyone across Canada if a trial is successful and the drug is approved –– but not necessarily, and maybe not anytime soon. More on that next time. Visit BioCanRx.com to learn more.Finally, the thoroughly hungover shell of Jen Gerson emerges from ten straight days of Calgary Stampede festivities with a political field report. Beneath the parties and pancake breakfasts, she says, the fractures within Canadian conservatism are becoming impossible to ignore. It's increasingly obvious who is and isn't willing to speak to whom. What should have been an outstanding month for Alberta Premier Danielle Smith has instead been overshadowed by self-inflicted drama. Meanwhile, Conservative leader Pierre Poilievre continues to struggle against political newcomer Carney. It's a remarkable — and, in many ways, surprising — dynamic to watch. Wasn't Poilievre supposed to be the political pro who'd mop the floor with the rookie Euro banker? Guess not!All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca and, always and forever, like and subscribe.Programming note: The Line is taking a two-week summer holiday. The podcasts will continue, but barring major news events, our page will be quiet for a few weeks. We need a break!#TheLinePodcast#MarkCarney#CanadianPolitics#CanadaUSRelations#PipelinePolitics#DanielleSmith#PierrePoilievre#CalgaryStampede#Geopolitics#CurrentAffairs

Growing up Mormon, Founder/CEO of Hailey Ann Co, Hailey Fernelius left the church as a teenager and has been Stepping Out of Line since the age of 12. Her out-of-line journey has encouraged her to question everything she was taught about success, work, money, and life. In this episode of the Step Out of Line Podcast, “Don't Believe In The Hustle Culture,”  we talk about building a life that actually feels good instead of following someone else's blueprint. We dive into why she doesn't believe in hustle culture, how your nervous system plays a bigger role in your finances than most people realize, and why rest is crucial to one's mental health.  We also get into her four archetypes (and why Peri is definitely the fight archetype), her wanderlust adventures, the lessons she learned working every position in a restaurant, how those experiences built the foundation for the business she has today, and more. If you've ever felt like there's only one "right" way to build a business, make money, or live your life, this conversation is a reminder that you get to create your own path.

In the latest episode of The Line Podcast, recorded on July 3rd, 2026, Matt Gurney and Jen Gerson begin with the biggest political news of the week: a pipeline deal. Prime Minister Mark Carney has struck agreements with both Alberta and British Columbia to move another pipeline project forward. Your hosts discuss the proposed route, which closely follows the existing Trans Mountain corridor, the political wheeling and dealing that made the agreement possible, and what it could mean for Alberta's upcoming referendum. Matt also can't help asking an obvious question: since this was always the logical outcome, why did it take so long? Was there a genuine engineering obstacle behind the scenes, or are Canadian governments simply incapable of moving quickly?This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Next, they turn to another round of comments from U.S. Ambassador Pete Hoekstra. After a brief discussion of CUSMA, the conversation shifts to Hoekstra's remarks about the Gordie Howe International Bridge. Your hosts aren't especially worried. In fact, they think they have the perfect strategy: troll the White House until it becomes so embarrassed that it can't wait to open the bridge just to make the pain stop. Their suggestions include live episodes of The View from the bridge deck, Bruce Springsteen concerts, and, naturally, renaming it the Barack Hussein Obama Nobel Peace Prize Bridge of Friendship.This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network focused on cutting-edge immunotherapy research that they're helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada.Clinical trials are the way new drugs, including immunotherapies, are tested in patients around the world. Health Canada, our national regulator, reviews and approves all Clinical Trial Applications, or CTAs, returning a decision within 30 days –– a similar turnaround time as the US FDA and other major jurisdictions. To submit a complete CTA, applicants need to provide hundreds –– sometimes thousands –– of pages of data showing that a drug has a compelling chance of providing benefit, that it can be manufactured consistently, and that it's safe to administer to trial participants. This is especially hard for Canadian researchers because scientific studies that generate the necessary data aren't supported by many federal grants, which usually prioritize originality over real world impact. BioCanRx helps Canadian researchers succeed in the CTA process, and so far they've gotten 16 therapies to trial. To learn more, visit BioCanRx.com.Finally, Matt attempts to diagnose what has gone wrong with Canada's civic culture and even ventures a possible cure. Toronto, he argues, needs its own version of the Calgary Stampede, and Canada more broadly needs something capable of genuinely uniting the country. The trouble is that neither host can think of an obvious candidate. They conclude that Canada — and Toronto in particular — has become too self-conscious and too embarrassed by its own past to celebrate it with much enthusiasm.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca.#TheLinePodcast#MarkCarney#PipelinePolitics#CanadianPolitics#CanadaUSRelations#CUSMA#GordieHoweBridge#AlbertaPolitics#PoliticalAnalysis#CurrentAffairs

Leadership isn't built in a boardroom. It's built through people, experience, and the stories that shape us.In this episode of The Line Podcast, I sit down with Ilya Tlumach, President of JM Lapp, for a conversation about leadership, legacy, and what it means to steward an organization you didn't found.We discuss Ilya's family's journey from Ukraine, the values that have been passed from generation to generation, and how those principles continue to shape the culture and leadership of JM Lapp today.Along the way, we dive into topics every leader wrestles with:The difference between flow and hustleBuilding systems without losing your peopleWhy proximity isn't the same as presenceHow leaders unintentionally become disconnected from their teamsPreserving a founder's vision while leading the next generation of growthWhether you're leading a business, building a team, or simply trying to become a better leader, this conversation is full of practical wisdom and timeless perspective.If you enjoy conversations about leadership, culture, the skilled trades, business growth, and building organizations that last, be sure to subscribe and share this episode with someone who would benefit from it.--------------------------WHERE TO WATCH:Spotify ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://open.spotify.com/show/07rT0hF...Apple ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://podcasts.apple.com/us/podcast...-------------------------FOLLOW JOSH:X: https://x.com/Joshuadmellott⁠⁠⁠⁠⁠⁠⁠⁠⁠... / joshuadmellott LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok:⁠⁠⁠⁠⁠⁠⁠⁠ / ucc11qg6hxwp7tmvmr_sv7vg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ --------------------------FOLLOW BLACKLINE: @blacklineltdInstagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / blacklinelt. .Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/profile.php?...LinkedIn: / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / @blacklineltd Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.blacklineltd.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠--------------------------EXPLORE THE PODCAST⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify: https://open.spotify.com/show/07rT0hF...Apple: https://podcasts.apple.com/us/podcast...

In today's episode of The Line Podcast, recorded on June 26th, 2026, Matt Gurney and Jen Gerson begin with a rare moment of joy. After decades of delay and political paralysis, there is finally a plan to deal with 24 Sussex Drive. Your hosts don't love every aspect of it, but they're so relieved that someone has finally decided to do something that they're prepared to celebrate. Now comes the hard part: not finding a way to mess it up.This episode of The Line Podcast is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers. To learn more, visit ap1000.cameco.com.From there, they turn to the tragic shooting in Montreal that claimed the life of another police officer. Beyond the immediate heartbreak, your hosts focus on two broader issues. First, they argue that the media should have published the shooter's manifesto. By choosing not to do so, they contend, some early reporting ended up being incomplete or inaccurate. Second, they discuss the rush by commentators across the political spectrum to comb through the manifesto looking for evidence that the attacker perfectly represented their opponents — or, failing that, had nothing whatsoever to do with their own side. Matt and Jen argue that modern terrorism is often ideologically incoherent, and that treating every attack as an opportunity for partisan point-scoring will only make it harder to understand and prevent future violence.This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Finally, Jen makes a wardrobe change that only video viewers will fully appreciate before walking Matt through the increasingly strange politics of the Calgary Stampede. What was once simply Alberta's biggest annual celebration is now becoming another front in an ongoing proxy war between competing factions within the broader conservative movement.This episode is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network, which helps bring cutting edge cancer immunotherapy research from Canadian scientists from labs to patients in clinical trials –– all in Canada. Cancer is very good at evading your immune system. But in some tumors, researchers find cancer-killing immune cells called tumour infiltrating lymphocytes, or TILs. They get inside the tumour and start fighting — but they're outnumbered and ill equipped. Researchers in Canada and around the world are studying techniques to extract them from a tumour and multiply them in a lab. Once they number in the millions, they're injected back into the tumour to do more damage. Research into this line of attack against cancer is ongoing. There are plenty of unanswered questions, and we're working hard to answer them. Learn more about this and other critical work at BioCanRx.com.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca, and as ever, like and subscribe.#TheLinePodcast#CanadianPolitics#24Sussex#Montreal#CalgaryStampede#AlbertaPolitics#PoliticalAnalysis#CanadianMedia#LawEnforcement #CurrentAffairs

We're so excited to welcome our friends, Rhonda & Jason Halbert (R.J. Halbert) to the podcast!Their story goes way back, as Jason first noticed Rhonda when he was just 8 years old, but they didn't start dating until high school. After about a year, Jason knew she was the one.Today, they are authors, creatives, entrepreneurs, and CEOs of a publishing company that has already signed a number of authors. As individuals, they each dislike the restrictions of following rules and are continuously Stepping Out of Line. It's simply a part of their DNA. R.J. Halbert's personal trauma led them to write a trilogy, journaling became such a powerful tool for processing emotions for Rhonda, and their books serve as a way to remember life's defining moments and remain grateful for the journey.In this episode of the Step Out of Line Podcast, “Faith, Creativity, And A Warm Bowl of Mac & Cheese,” we talk about faith, the supernatural strength that helps us face adversity, and the creative process, including how that final 5% of creativity can sometimes unlock the sum of a project, as well as Peri's upcoming author journey, The Peri Project, and more. While R.J. Halbert's books aren't a mirror to their own life experiences, the emotions behind them are. The Goodpasture Chronicles series may be fiction, but the heart of the story remains the same.We first connected with Jason when he appeared on the podcast in 2021, and we've all been friends ever since. Today, Rhonda and Jason are two of Peri's closest mentors, which made this conversation all the more special.

Chad Albrecht is a Master Gunsmith, Certified AR15 Armorer, and Technical Instructor. He founded School of the American Rifle in 2015 which specializes in the quintessential "American Rifle", the AR15. His passion is sharing his technical knowledge and experience so his students can maximize reliability and accuracy potential from their AR15. To learn more about Chad's work visit SchooloftheAmericanRifle.com and watch him @ SchooloftheAmericanRifle.   RELATED PODCASTS: Inside Radian Weapons | Higher Line Podcast #81 Building Warriors | Higher Line Podcast #234 Cutting through the BS with Fisher Blades | Higher Line Podcast #264   ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

In the latest episode of The Line Podcast, recorded on June 19th, 2026, Matt Gurney and Jen Gerson begin with a foreign affairs roundup. Prime Minister Mark Carney heads to Ireland and France to strengthen ties with Europe while also trying to maintain a workable relationship with Donald Trump. Meanwhile, U.S. Defense Secretary Pete Hegseth visits NATO and delivers some pointed criticism of allies that, while not directed at Canada by name, certainly sounds familiar. Your hosts also discuss the aftermath of America's confrontation with Iran. Matt argues that the United States has, in practical terms, suffered a defeat — an embarrassing outcome for Trump, but perhaps a useful lesson for the rest of us about the limits of military power.This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness' in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.Find them Fractional-Execs.ca.Next, they take a quick tour through the provinces. Matt is increasingly worried that Doug Ford could inadvertently throw Canada-U.S. negotiations into chaos, and explains why. Jen provides an update from Alberta, where the political situation remains bizarre. By the end of the segment, both hosts arrive at a grim conclusion: the incentives facing almost every major political actor now reward escalation, confrontation, and nastiness. That rarely ends well.This episode of The Line Podcast is also brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network helping Canadian researchers bring treatments from labs to patients in clinical trials –– all in Canada.Every day, your immune system finds and destroys different types of threats –– both external invaders like viruses, and internal dangers like pre-cancerous cells in your own body. But cancer can sometimes evade detection. Researchers are working to identify flags found on cancer cells, called antigens. By training your immune system to recognize these antigens, immunotherapy can help your immune system destroy cancer. In addition to funding clinical trials, BioCanRx supports research teams who identify these cancer antigens, and find new ways to target them. Many challenges remain — and we're working on solving them. You'll hear more over the summer. For now, go to BioCanRx.com to learn more.Finally, Jen disappears down one of her trademark rabbit holes and emerges with a sweeping explanation of how she came to fully appreciate the sheer economic power of the United States. Somehow, this journey involves gas pumps, brisket, beef jerky, the Soviet Union, and the defeat of Imperial Japan in 1945. Your hosts find themselves reflecting on what American economic dominance really means, why it has proven so durable, and what lessons Canada should draw from it as we navigate an increasingly uncertain world.All that and more in the latest episode of The Line Podcast. Check us out on our main page, ReadTheLine.ca.#TheLinePodcast#MarkCarney#DonaldTrump#CanadaUSRelations#AlbertaPolitics#DougFord#CanadianPolitics#Geopolitics#NATO#CurrentAffairs

In today's On The Line, host Jen Gerson speaks with Mark Kawar, an amateur historian and journalist whose book America But Bigger explores a surprisingly persistent feature of American history: attempts to expand the United States beyond its current borders.This episode of On The Line is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network helping Canadian researchers bring treatments from labs to patients in clinical trials –– all in Canada. Cancer can hide from your immune system. So how can we target it? Every day, your immune system finds and destroys different types of threats –– both external invaders like viruses, and internal dangers like pre-cancerous cells in your own body. But no system is perfect — sometimes something evades detection. Researchers are working to identify flags found on cancer cells, called antigens. By training your immune system to recognize these antigens as signals for destruction, some forms of immunotherapy equip your immune system to respond to cancer's asymmetrical threat.   In addition to funding clinical trials, BioCanRx supports research teams who identify cancer antigens, and find new ways to target them with immunotherapies. There's still a lot to figure out. Can we train the immune system to hit these antigens before cancer takes root? Why do some cancers still manage to evade therapies designed to find their antigens? Many other questions remain — and we're working on answering them. You'll hear more over the summer. For now, go to BioCanRx.com to learn more.Kawar walks Gerson through the long history of American expansionist ambitions, from schemes that never got off the ground to serious efforts that came much closer to success than many people realize. Along the way, he notes that not every annexation proposal was unwelcome to the people being annexed, and that the historical record is often more complicated than simple stories of American aggression.This episode is also brought to you by the Forest Products Association of Canada. A stronger forest industry means investing in the mills and facilities that anchor communities across Canada. Companies are ready to modernize with cleaner equipment, better energy efficiency, advanced wood products, biomaterials, and smarter use of every part of the tree. These are productive, lower-emission, export-oriented investments. But good projects need a workable business case. Our economy needs practical tools to unlock private capital and keep investment here. Learn more at fpac.ca.More importantly, Kawar examines why so many of these projects ultimately failed. The United States has often possessed enormous economic, military, and political power, but translating that power into lasting territorial expansion has proven more difficult than many Americans imagined. Again and again, resistance, geography, politics, and simple practicality imposed limits on what even the world's most powerful country could accomplish.The result is a fascinating conversation about ambition, empire, national identity, and the often-overlooked constraints on American power. It's also a discussion that may hold some lessons for Canadians, should they ever find themselves wondering about the limits of U.S. influence. For whatever reason.This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.Visit our main page at ReadTheLine.ca. Be sure to like and subscribe. We'll be back on Friday with another episode of The Line Podcast.#Canada #Politics #UnitedStates #Greenland #annexation #51 #51State #OnTheLine

Well folks its been fun... 8 years since we started. We made some friends, and we pissed off some friends for reasons we will never understand....Over the 8 years on the show, we have had some of the best of the best (Anglers, tackle manufacturers, fly tyers) in the world and some people who turned out to be horrible 2 faced people that we regret giving time to.... but ultimately, getting you connected and sinking your dentition into the beef while keeping our feet firmly planted on the benthic strata has been an experience that has often seen us "arksking" ourselves why we do it, and the answer has always resoundingly been, to share the love and the betterment of the sport with humility and without ego or politics, based on our own very real experiences that spans now almost 60 years between the 2 hosts. For the most part, we have thoroughly enjoyed our experience, and we hope that we have left you with a new approach to Fly Fishing that involves curiosity, ethics, motivation, a focus on the fishing and an awareness of who the real deal is in this game that can take up so much of your time and money.. but its rewards are priceless.   That is all. 

In the latest episode of The Line Podcast, recorded on June 12th, 2026, Matt Gurney and Jen Gerson begin with an update from Alberta. Jen reviews Pierre Poilievre's recent speech on why Alberta belongs in Canada. She liked it, with some caveats. Matt was somewhat more encouraged. He also has a few sharp words for Liberals who seem determined to police the boundaries of acceptable federalism. His view is simple: if people are defending Canada, let them defend Canada. Not every argument for national unity needs to come packaged with Liberal talking points. From Toronto, Matt also reflects on a genuine tragedy this week — a police officer killed in the line of duty while confronting a problem that had been allowed to fester for far too long. It's difficult to discuss without emotion. In his view, it never should have ended this way. But, alas, it was always going to: even if the exact tragedy was unforeseen, a tragedy was inevitable. This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.The hosts then take a very different turn. In what may be the strangest segment of the year, Jen reimagines 250 years of Canada-U.S. relations as a raunchy romantic comedy full of love, betrayal, heartbreak, and, yes, sex. Video viewers can watch Matt become increasingly horrified as the bit unfolds — not because he disagrees with the analysis, but because he finds himself unable to refute it.This episode is also brought to you by BioCanRx, a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Immunotherapy is about assisting your immune system in identifying unhealthy cells –– especially cancer –– that have found a way to evade detection. One way researchers are doing this is through something called CAR T. They draw your blood, isolate one type of your immune cells –– T-Cells –– and use a virus to inject genetic instructions that cause them to grow new receptors designed specifically to find and destroy your particular cancer. In one of the 16 trials BioCanRx funds based on Canadian technology, CLIC-01, the median number of months remaining for patients with late-stage leukemia and lymphoma tripled. Some have been cancer free for years.You'll hear more over the summer. For now, go to BioCanRx.com to learn moreAfter that, the hosts wrap up with a discussion about children and social media. Both agree that kids probably shouldn't be spending their lives online. Their concern is that any attempt by the government to solve that problem could easily create several new ones. If recent experience is any guide, they aren't especially confident Ottawa can regulate this area without making a mess of it.All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca, and, as ever, like and subscribe. #TheLinePodcast#PierrePoilievre#AlbertaPolitics#CanadianPolitics#CanadaUSRelations#SocialMedia#Parenting#NationalUnity#PoliticalPodcast#CurrentAffairs

If you knew you had to hear 50 nos before getting to a yes, wouldn't you be excited to collect every single no?As the co-host of The Naked Room podcast, CEO of Hey Y'all!, and brand storyteller, Kelly Garthwaite has guided her career by a mindset defined by bold pivots, creative reinvention, and an unwavering commitment to her purpose. We first connected with Kelly through Entreprenista, and from the moment we met her, it was clear she isn't afraid to step outside the lines in pursuit of what truly lights her up.By trusting her instincts, embracing change, and staying connected to her "why," Kelly has navigated multiple career shifts while building a life and business aligned with her values. Whether she's behind the camera, behind the microphone, or helping brands tell meaningful stories, she continually follows the things that make her tick and refuses to lose sight of her North Star.In this episode of the Step Out of Line Podcast, "Never Lose Sight of Your North Star," we talk about entrepreneurship, storytelling, rejection, resilience, and the power of trusting your inner voice. Kelly shares why rejection is simply part of the journey, how unexpected pivots can lead to your greatest opportunities, and what it takes to keep moving toward the life you're meant to build.This conversation is a reminder that success isn't always a straight line, and that every no brings you one step closer to the right yes.

In this episode of On The Line, host Matt Gurney is joined by two guests for conversations about politics, technology, and trust.This episode of On The Line is brought to you by BioCanRX, a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Can science help your immune system detect and destroy cancer? Immunotherapy is about assisting your immune system in identifying unhealthy cells –– especially cancer –– that have found a way to evade detection. One way researchers are doing this is through something called CAR T. They draw your blood, isolate one type of your immune cells –– T-Cells –– and use a virus to inject genetic instructions that cause them to grow new receptors designed specifically to bind with your particular cancer. When those cells are re-infused into your body, they hopefully will be able to find and destroy your cancer.  The results are promising. In one of the 16 trials BioCanRx funds based on Canadian technology, CLIC-01, the median number of months remaining for patients with late-stage leukemia and lymphoma tripled. For some, the response was even bigger: they went from being out of options to cancer free, and have stayed that way for several years.Many questions remain — and we're working on answering them. You'll hear more over the summer. For now, go to BioCanRX.com to learn more.First up is PJ Fournier of 338Canada for a look at the latest political numbers. They discuss the good news for Mark Carney, the bad news for Pierre Poilievre, and why the Liberal numbers may not be quite as strong as they first appear. The conversation then turns to Quebec, where the next provincial election is shaping up to be one of the strangest contests either man can remember. Fournier struggles to find a historical comparison. They also discuss softening support for separation in Quebec, how that compares with developments in Alberta, and a point Matt makes that PJ suspects may not be especially popular with Quebec nationalists — even if he doesn't disagree with it.Then Matt is joined by David Shipley of Beauceron Security for a discussion about artificial intelligence, social media, and the growing gap between technological change and political institutions. How much of the current AI boom is real, and how much is hype fuelled by companies racing toward public offerings? Shipley argues that Canadians deserve greater transparency around the Tumbler Ridge case, while Matt notes that he can't even get straightforward answers about transit delays, leaving him less than optimistic about the prospects for accountability.This episode is also brought to you by the Forest Products Association of Canada. A stronger forest industry starts with predictability. Mill modernization, bioenergy, mass timber, and advanced biomaterials all depend on reliable access to usable Canadian wood fibre, workable timelines, and clear rules. Provinces lead forest management, and the federal role should be coordinated, complementary, and focused on results. Every unnecessary delay makes it harder to keep jobs and attract investment. For a sector rooted in communities, regulatory efficiency is economic policy. Learn more at FPAC.ca.The conversation also examines how major social media platforms are being exploited for fraud and manipulation, an issue Shipley has been testifying about. The core problem, he argues, is that the internet moves at the speed of light while politicians move at the speed of Parliament. That mismatch is creating vulnerabilities that are only getting worse. The episode closes with a warning to Albertans heading into a possible referendum campaign: Shipley isn't telling anyone how to vote, but he is urging people to be extremely careful about what they believe online. Foreign interference efforts are already arriving, and they're unlikely to get less sophisticated from here.This episode is also brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That's why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.Check out our main page at ReadTheLine.ca and be sure to like and subscribe. We'll be back on Friday with another episode of The Line Podcast.#OnTheLine #CanadaPolitics #338Canada #PJFournier #MarkCarney #PierrePoilievre #QuebecPolitics #AlbertaPolitics #ArtificialIntelligence #CyberSecurity #DavidShipley #ForeignInterference #MattGurney

In the latest episode of The Line Podcast, recorded on June 5th, 2026, Matt Gurney and Jen Gerson begin with reports that Prime Minister Mark Carney has a tendency to raise his voice behind closed doors when dealing with his Liberal caucus. According to reporting in the Toronto Star, the PM may not always be the calm technocrat he appears to be in public. Your hosts cannot endorse a toxic workplace, of course, but they also suspect many Canadians won't be especially upset by the news. After all, they argue, a lot of voters chose the Liberals out of necessity rather than affection, and more than a few people might conclude that after a decade of terrible Liberal management, the former PM's leftovers deserve a real chewing out.This episode is brought to you by the Forest Products Association of Canada. Canada's forest industry is a national economic anchor rooted in hundreds of communities across the country. The Canadian Forest Sector Transformation Task Force was created to chart a path toward a stronger, more competitive, and more resilient sector. That means practical federal action on long-standing priorities: stronger supply chains, better productivity, more homes, and regional resilience. Learn more at FPAC.ca.After that, they discuss Carney's recent efforts to reassure Canada's Jewish community. Both hosts agree the attempt fell short. Matt argues that putting Marc Miller in charge of a new advisory panel feels like a very Trudeau-era response to a serious problem — process instead of action. Jen then raises reports that the Trump administration may consider offering asylum to Canadian Jews. She also notes, to Matt's horror, that he warned months ago that such a possibility could eventually arise. Perhaps, they joke, he manifested it.This episode is also brought to you by BioCanRx. Nearly half of all Canadians will face a cancer diagnosis in their lives, and Canadian scientists are racing to build better treatments. But it's not just the science — it's the logistics of actually getting it to patients.BioCanRx is a federally funded, not-for-profit research network that specializes in moving Canadian cancer immunotherapy from the lab to clinical trials here at home. Since 2015, they've funded sixteen trials and treated more than four hundred patients — all with made-in-Canada technology.So what is immunotherapy? Your immune system eliminates threats every day, including your own cells when they mutate. But sometimes mutating cells are able to evade the immune system — and that's usually when we call them cancer. Immunotherapy supports or modifies your immune system so cancer can't slip past it.Stay tuned this summer, and visit BioCanRx.com to learn more.Finally, the hosts check back in on Alberta after what was, by recent standards, a surprisingly quiet week. Probably won't stay that way for long, though. It never does.Also: Ricky Martin reference!All that and more in the latest episode of The Line Podcast.#TheLinePodcast#MarkCarney#CanadianPolitics#CanadaPolitics#AlbertaPolitics#MarcMiller#CanadianJews#MediaAnalysis#FederalPolitics#CurrentAffairs

In this episode of On The Line, host Jen Gerson sits down with James McLeod of the Canadian Shield Institute to discuss one of the most talked-about — and least understood — concepts in Canadian public policy: digital sovereignty.This episode of On The Line is brought to you by BioCanRX. Nearly half of all Canadians will get a cancer diagnosis in their lives. Canadian scientists are moving fast to come up with better treatments to help these people. But it's not just about science, it's about the logistics of implementing it.  BioCanRx is a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Since launching in 2015, they've funded 16 clinical trials and treated more than 400 patients across Canada, all with made-in-Canada technologies.What is immunotherapy? Most immune systems successfully eliminate threats every day –– including our own cells when they mutate in ways they shouldn't. But when our mutating cells find a way to trick our immune systems, things can start getting out of control. That's usually when we apply the label "cancer." Immunotherapy is about modifying or supporting your immune system so cancer can't evade it. Stay tuned this summer to learn more about what Canadian research is doing to fight cancer. Go to BioCanRX.com to learn more.The word “sovereignty” has become a fixture of Canadian political debate in recent years, particularly in response to economic pressure and even annexation rhetoric from U.S. President Donald Trump. But what does sovereignty actually mean in a world where much of Canada's digital infrastructure, cloud computing, social media, and online services are controlled by American companies and governed by American laws?McLeod walks Gerson through the realities of living in a digital ecosystem largely built and operated south of the border. They discuss the vulnerabilities that creates for Canada, the limits of what governments can realistically do to regain control, and the difficult trade-offs involved in pursuing greater independence over data, privacy, and critical digital infrastructure.This episode is also brought to you by the Forest Products Association of Canada. Canada's forest industry is a national economic anchor rooted in hundreds of communities across the country. The Canadian Forest Sector Transformation Task Force was created to chart a path toward a stronger, more competitive, and more resilient sector. That means practical federal action on long-standing priorities: stronger supply chains, better productivity, more homes, and regional resilience. Learn more at FPAC.ca.The conversation also explores what a Canadian digital sovereignty strategy might actually look like in practice. Can Canada build more domestic capacity? Should it? And what kinds of regulatory and policy tools are available to a middle power trying to assert greater control in a digital world dominated by American technology giants?It's a timely discussion about privacy, security, national resilience, and what sovereignty means in the twenty-first century. Check out our main page at ReadTheLine.ca and be sure to like and subscribe. We'll be back on Friday with another episode of The Line Podcast.#OnTheLine #DigitalSovereignty #Canada #Technology #Privacy #CyberSecurity #DataPrivacy #CanadianPolitics #JenGerson #JamesMcLeod

In the latest episode of The Line Podcast, recorded on May 29, 2026, Matt Gurney and Jen Gerson begin with discussion of Prime Minister Mark Carney's trip to New York and the state of Canada-U.S. trade negotiations. Your hosts debate whether Canada has actually surrendered ground in the talks or merely put an opening offer on the table. They also discuss Carney's popularity. Matt remains eager to see more concrete accomplishments, but he concedes that, at least for now, the prime minister is decisively winning the vibes war.This episode of The Line Podcast is brought to you by Electro-Federation Canada. Canada's clean electricity grid gives us a competitive edge in attracting global investment — but to maintain that advantage our system needs to break down barriers and unlock the grid. Aging infrastructure, supply chain constraints, and outdated regulations threaten our ability to expand and modernize the grid — essential components of meeting future capacity needs. Electro-Federation Canada has developed a research-backed roadmap for grid readiness focused on smart policy and regulatory alignment. To learn more, visit MakeTheSwitch.ElectroFed.com.Next, Jen asks Matt to explain the Swedish aircraft Canada is buying, giving him an opportunity to walk listeners through the logic behind the deal. Is this a new line for Canada, or just Carney buying himself the room to buy some U.S. equipment next? That conversation quickly expands into a broader rant about Canada's inability to simply get important things done. Once again, governments are creating new mechanisms, new processes, and new workarounds to accomplish tasks that functioning countries often manage through their existing institutions.This episode of The Line Podcast is also brought to you by Dominion Dynamics. Canada has never had true sovereign awareness of our North. Vast parts of our country are a blind spot. And when you can't see your own territory, you can't defend it, secure it, or respond when threats emerge. Dominion Dynamics is changing that. Dominion Dynamics is building a sovereign command and control capability that lets Canada and its allies see, respond, and defend across every domain. Dominion is starting in the Arctic, where extreme conditions demand technology no one else can deliver.Defend the Dominion. Dominion Dynamics.Learn more at DefendTheDominion.com.In the final segment, the hosts return to Alberta and the ongoing federalist-versus-separatist debate. They spend considerable time discussing what role, if any, Canadians outside the province should be playing in the conversation. Can outsiders help the federalist cause, or do they risk making matters worse? Matt and Jen don't agree on every detail, but both recognize that the stakes extend well beyond Alberta itself.All that and more in the latest episode of The Line Podcast.#TheLinePodcast#MarkCarney#CanadaUSRelations#TradeNegotiations#CanadianPolitics#AlbertaPolitics#Federalism#PierrePoilievre#DefencePolicy#Geopolitics

What's the difference between marketing and advertising and why does it matter for your pharmacy?  In this episode of the Bottom Line Pharmacy Podcast, Austin Murray sits down with Bruce Kneeland, longtime independent pharmacy advocate and host of the Pharmacy Crossroads podcast, for a candid conversation about what it really takes to grow an independent pharmacy in today's competitive landscape. Bruce shares his fascinating journey from a chance job posting at BYU that landed him in Fargo, North Dakota, to senior roles at Health Mart, AmerisourceBergen, and eventually becoming a consultant and road-tripper who has visited pharmacies coast to coast. In this episode, Bruce and Austin cover: - Marketing vs. advertising and why confusing the two is costing pharmacies patients - The word-of-mouth myth and why relying on it alone is "killing you slowly" - Messaging that connects how to talk about complex services like compounding in language patients actually understand - The B2B opportunity and why your real customer for compounding and specialty services might be the prescriber, not the patient And more!

Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm's Investigations + White Collar Defense Group, hosted the fourteenth episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector.

London 2012 may have broken many runners, but for Shannon Rowbury, it lit a fire that never went out.As an Olympic runner in what is now known as one of the most controversial women's 1500-meter finals of all time, Shannon refused to let that race define her. Instead, she used it as fuel, building a future that extends far beyond the track and field and into a legacy her children can be proud of. Today, Rowbury is an author, speaker, entrepreneur, sports commentator, and coach who believes there are no limits to what's possible. Alongside her husband, she co-founded the Imagining More Foundation and running camp, helping the next generation of athletes reimagine their competitive mindset. After co-authoring two books, building community in sport, and teaching leadership and team strategy in the corporate and educational world, Shannon had come to accept that the chance for a fair 2012 Olympic outcome had already passed. Then came the news: she will be awarded a medal at the 2028 Olympic Games in Los Angeles for her performance at the 2012 Olympic Games in London. Sometimes, even years later, truth finds its way forward, and what was always deserved becomes a full-circle moment. Between now and the 2028 games, Shannon is determined to write her story through her own memoir and create a documentary alongside other creatives and fellow runners. We cannot wait to see where these next few years take her! In this episode of the Step Out of Line Podcast, “This Medalist's Mindset,” we explore the marathon mindset, motherhood, and the athletic journey, the importance of storytelling and sharing our truths, and more. Be sure to tune in!

Jiu-Jitsu Professor Chris "Bones" Burns from down under shares how he came the art, drawing comics, a love for guns and transitioning to family life. Chris was born in the United States, but as the son of a world traveler talks about self-defense around the globe.   Chris Bones is a 3rd Degree Rickson Gracie Black Belt leading Zero Point Gracie Jiu-Jitsu Academy in Sidney, Australia. To learn more about Ryan Chris "Bones" Burns visit his website at ZeroPointGJJSydney.com or follow him on Instagram @chrisbonesjj.   RELATED PODCASTS:   Health Hacks Aren't Hacks at All | Higher Line Podcast #267 Cutting through the BS with FisherBlades | Higher Line Podcast #264 AMERICA'S Jiu-Jitsu Hero | Higher Line Podcast #255 ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

Why Raiders of the Lost Ark Still Defines the Perfect Adventure MovieIn this episode of Review It Yourself, we dig into one of the most iconic adventure films ever made: Raiders of the Lost Ark. Joining the show is Ryan Walker, host of The Walk The Line Podcast, for a lively and often hilarious discussion about the film that launched the legendary archaeologist Indiana Jones into pop-culture history.Together we explore why this classic directed by Steven Spielberg and starring Harrison Ford continues to influence modern cinema decades after its release. From unforgettable set pieces and practical effects to the film's pacing, villains, and iconic moments, this episode breaks down what makes Raiders such an enduring favourite.But it wouldn't be Review It Yourself without a few disagreements. While many fans consider Raiders the pinnacle of the original Indiana Jones trilogy, the conversation dives into whether it truly stands above entries like Temple of Doom or The Last Crusade.Along the way, we also talk about nostalgia, blockbuster storytelling, and the changing nature of heroes in modern movies.Expect passionate opinions, film geek deep dives, and plenty of laughs as we revisit one of the greatest adventure films ever made.What We Discuss In This EpisodeWhy Raiders of the Lost Ark is considered a masterpiece of adventure filmmakingThe legacy of Indiana Jones and why the character still resonates todayMemorable scenes, villains, and practical effects that defined the filmHow blockbuster storytelling has evolved since the early 1980sWhether the original Indiana Jones trilogy still holds up todayWhy practical effects often feel more impactful than modern CGIGuest: Ryan Walker – Walk The Line PodcastThis episode features Ryan Walker, host of the Walk The Line Podcast, where he explores stories, culture, and engaging conversations with a unique perspective.Follow and listen to Ryan here:Podcast: The Walk The Line PodcastSearch The Walk The Line Podcast on your favourite podcast platform.About Review It YourselfReview It Yourself is the podcast where we break down films, TV, and pop culture with honest opinions, humour, and a fresh perspective. If you enjoy deep dives into classic movies, debates about beloved franchises, and thoughtful discussion about storytelling, this is the show for you.Follow Review It YourselfStay connected and join the conversation:Instagram: https://www.instagram.com/reviewityourselfpodcast2021X / Twitter: https://twitter.com/YourselfReviewBlueSky: https://bsky.app/profile/reviewityourself.bsky.socialThreads: https://www.threads.net/@reviewityourselfpodcast2021

2nd Amendment attorney Ryan Cleckner started his career as a US Army Ranger Sniper serving two combat deployments to Afghanistan. He best known for authoring the "Long Range Shooting Handbook," and "Advanced Long Range Shooting." Cleckner earned a law degree now champion's firearm rights with a variety of companies including Rocket FFL and Gun University. To learn more about Ryan Cleckner visit his website at RyanCleckner.com. RELATED PODCASTS: He Wrote the Book on Self-Protection | Higher Line Podcast #203 Solving the 2nd Amendment Debate | Higher Line Podcast #241 Gun Safes – Myths, Lies and Secrets | Higher Line Podcast #266 ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

Courtney "Bear" Sills is one of the entertainment industry's most innovative figures. His goal is to inspire the youth and assist them with understanding that their mind is their strongest muscle. Sills is a founding member of the label imprint No Face No Case that launched in 2019. He served as an associate producer of the VH1 documentary "The Untold Story of Atlanta Rise," and is a partner in the beverage brand Crip-a-Cola/Blood Pop alongside Killer Mike, where he also functioned as a casting agent on behalf of the brand for the series "Trigger Warning," on Netflix. Bear Sills is passionate about uplifting and strengthening black communities. He leads Bear Stong, a non-profit "committed to fully addressing socio-cultural factors impacting the social and emotional development of minority males youth. We will provide effective youth development  programs to assist with uplifting, conflict management, raise awareness about education and establish ways to assist these young men with progressing forward by utilization of best practices that improve learning and mindful development"   To learn more check out bearstrongnp.org and follow Bear @BearStrongNPO on Instagram.   RELATED PODCASTS:   What Are Your Standards? | Higher Line Podcast #50 The Truth | Higher Line Podcast #148 Fundamentals are the Key to Creativity | Higher Line Podcast #130  ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.

Ashley Hlebinsky, executive director of the Firearms Research Center, is one of the foremost authorities on firearms history and material culture in the United States. For a decade, she was Curator in charge of one of the largest firearms museums in the country and served as Project Director on the museum's full-scale multimillion dollar renovation. Presently, Hlebinsky serves as a museum consultant, speaker, writer, expert witness, and television host and producer. To learn more check out firearmsresearchcenter.org and follow Ashley @HistoryinHeels on instagram   RELATED PODCASTS:   This Lady Can Shoot! | Higher Line Podcast #259 History that Deserves to be Remembered | Higher Line Podcast #131 Swordsman with Words | Higher Line Podcast #79 ---   Music Attributions: Intro - "3rd Eye Blimp" by Otis McDonald Outro - "I Want More" by Silent Partner   The Carry Trainer Higher Line Podcast is available on iTunes, Google Play, YouTube, Stitcher and most importantly CarryTrainer.com.